Antibiotics Have Limited Effect On Invasive Strep Infections, Study Finds

Doctors May Need Up to 110,000 Strep Prescriptions to Prevent a Single Invasive Strep Case

Strep throat is one of the most common reasons parents rush their children to the doctor. When the test comes back positive, the next step feels obvious: get some antibiotics, stop the spread, prevent something worse. But a new model-based analysis takes direct aim at a key assumption behind that logic, specifically the idea that prescribing antibiotics for a run-of-the-mill sore throat meaningfully protects children from a rare but life-threatening form of strep infection.

Group A Streptococcus, the bacteria behind classic strep throat, can in some cases break through the body’s defenses and attack internal tissues, sometimes causing flesh-eating disease, toxic shock, or sepsis. This is known as invasive group A streptococcal infection, far more dangerous than the sore throat that precedes it, and one that kills some patients while leaving others with permanent damage.

Despite rising rates of this severe infection in recent years and growing pressure on doctors to prescribe more aggressively, the researchers argue that fear of this complication should not be driving antibiotic decisions for ordinary sore throats. Whether treating the mild version can stop the deadly version is a question with real consequences for millions of prescriptions written every year.

The Numbers Behind Antibiotic Prescriptions for Sore Throat

Researchers based in Sweden compiled existing published evidence on how strep bacteria spreads through communities, how often people seek care for sore throats, and how effectively antibiotics interrupt that transmission. They combined those figures with real population data from Sweden at the end of 2024, roughly 2.3 million children and 8.3 million adults, along with recorded cases of the invasive infection that year. Sweden saw 163 invasive cases in children and 1,152 in adults in 2024, a figure the paper describes as “unusually high.” Published in the International Journal of Infectious Diseases, the analysis is based on the Swedish population and is most relevant to high-income countries; it may not apply in places where skin infections drive more strep transmission.

Rather than running a traditional clinical trial, the team built a framework of assumptions drawn from prior published research and ran them through multiple scenarios. One tool they examined is the Centor score, a four-point checklist widely used to triage sore throat patients. Its criteria are a history of fever, swollen tender lymph nodes in the neck, white patches on the tonsils, and the absence of a cough. Researchers modeled several thresholds, from testing only the highest-risk patients to testing virtually everyone.

Under the most aggressive possible scenario, where every sore throat patient who sees a doctor gets swabbed and every positive result gets antibiotics, the analysis estimates that 4.5% of invasive infections in children and 1.9% in adults could be prevented. Even with assumptions pushed in the most optimistic direction, the ceiling was 6.7% for children and 2.8% for adults.

When the researchers modeled realistic guidelines, testing only patients who score high on the Centor checklist, the estimated share of preventable invasive infections dropped to 1.1% in children and 0.76% in adults. To put those odds in concrete terms, the team calculated how many patients would need an antibiotic prescription to prevent a single invasive case. That number ranged from 12,000 to 110,000 depending on the testing strategy.

Why Antibiotics for Strep Throat Can’t Prevent Most Dangerous Infections

Part of the answer lies in the basic math of how the infection spreads. Most people with strep sore throats never see a doctor at all. Those who do often wait until day three or later, by which point they have already been contagious for days. And roughly 15 to 25% of invasive cases acquire the bacteria from a carrier with no signs of illness at all. That group, the researchers note, should not be prescribed antibiotics.

No prior research clearly establishes whether treating a sore throat prevents that same person from developing the invasive form of the disease. One referenced study found that all patients with confirmed strep tonsillitis who later developed the invasive infection did so despite having already received appropriate antibiotic treatment.

What Doctors Should Do Instead

Antibiotics do have a role in treating sore throats. What the researchers contest is that preventing rare, dangerous complications should be the reason to prescribe them. Rather than trying to prescribe away the risk of invasive disease, they argue health systems should get much better at recognizing it early. Straightforward decision tools already exist to help clinicians catch early warning signs in sore throat patients, the paper notes.

Expanding testing criteria would also dramatically increase the burden on primary care. Lowering the screening threshold would push required annual throat swabs from 110,000 to 290,000 in children and from 420,000 to 1,200,000 in adults, based on 2024 Swedish figures, reducing access for other patients in the process. Looking further ahead, the paper points to a strep vaccine as the most promising long-term solution.

Prescribing antibiotics for a sore throat will remain part of medicine. But the data make clear that handing out more of them is not a meaningful strategy for stopping a dangerous infection that often spreads before a doctor has any chance to intervene.

---

Disclaimer: This article is intended for general informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider regarding treatment decisions for strep throat or any other medical condition.

---